72.11.Z - Scientific research and development activities
20.42.Z - Manufacture of cosmetics and toilet preparations
20.59.Z - Manufacture of other chemical products, not elsewhere classified
21.10.Z - Manufacture of basic pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
22.22.Z - Manufacture of plastic packaging
46.46.Z - Wholesale trade of pharmaceutical and medical products
46.75.Z - Wholesale trade
72.19.Z - Scientific research and development activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Gross profit (loss) | -15 | -13,2 | -3,8 | 71,4 |
EBITDA | -15 | -13,2 | -3,8 | 71,4 |
Short time liabilities | 1,9 | 0,7 | 0,7 | 3,5 |
Equity capital | 25,2 | 12 | 8,2 | -31,6 |
Operating profit (EBIT) | -15 | -13,2 | -3,8 | 71,4 |
Assets | 27,1 | 12,6 | 8,9 | -29,7 |
Net profit (loss) | -15 | -13,2 | -3,8 | 71,4 |
Cash | 21,5 | 6,8 | 2,4 | -64,8 |
Net income from sale | 0 | 0 | 0 | 0 |
Liabilities and provisions for liabilities | 1,9 | 0,7 | 0,7 | 3,5 |
Working assets | 27,1 | 12,6 | 8,9 | -29,7 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | -59,6 | -110,8 | -46,3 | 64,5 |
Equity capital to total assets | 92,9 | 94,6 | 92 | -2,6 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 2 147 483 648 | 2 147 483 648 | 2 147 483 648 | 0 |
Current financial liquidity indicator | 14.106965065002441 | 18.51966094970703 | 12.570268630981445 | -5,9 |
Net dept to EBITDA | 1.429675579071045 | 0.5100501775741577 | 0.6275283694267273 | 0,1 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane